Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prescribing incentive schemes : a useful approach?

Anne R Mason1, Michael F Drummond, Jane A Hunter

  • 1Centre for Health Economics, University of York, Heslington, York, England. arm10@york.ac.uk

Applied Health Economics and Health Policy
|September 16, 2005
PubMed
Summary

Primary care organisations (PCOs) in England implemented diverse prescribing incentive schemes. While varied, these schemes aimed to encourage quality prescribing, though their effectiveness requires further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Clinical and Cost-Effectiveness of a Victim Improvement Package (VIP) for the Reduction of Chronic Symptoms of Depression or Anxiety in Older Victims of Community-Crime: the VIP RCT Synopsis.

Public health research (Southampton, England)·2026
Same author

The VIP trial: a randomised controlled trial of the clinical effectiveness of a Victim Improvement Package (VIP) for the reduction of continued symptoms of depression or anxiety in older victims of community crime in an English city.

BMJ open·2025
Same author

Host-response testing with MeMed BV in community-acquired pneumonia: an economic evaluation from the UK NHS perspective.

JAC-antimicrobial resistance·2025
Same author

Cross-agency working when conducting a pragmatic RCT for older victims of crime: our experiences and lessons learned.

Trials·2025
Same author

Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024
Same author

Colonoscopy vs the Fecal Immunochemical Test: Which is Best?

Gastroenterology·2024

Area of Science:

  • Health Services Research
  • Pharmaceutical Policy
  • General Practice Management

Background:

  • Primary care organisations (PCOs) in England were mandated to run prescribing incentive schemes for general practices between 2000-2004.
  • A statutory framework guided scheme design, including targets, rewards, and 'good cause for failure' clauses.

Purpose of the Study:

  • To evaluate the nature and potential utility of prescribing incentive schemes in promoting high-quality prescribing.
  • To explore how PCOs interpreted and implemented statutory requirements for these schemes.

Main Methods:

  • A review of prescribing incentive schemes was conducted by requesting copies from all PCOs in England.
  • Data extraction focused on rewards, budgetary targets, and specific conditions within the schemes.

Related Experiment Videos

Main Results:

  • Scheme finalisation varied, with some PCOs lacking schemes or offering no rewards.
  • Incentive schemes displayed significant diversity in structure, complexity, and reward levels, despite covering similar therapeutic areas.
  • Over 50% of schemes lacked a 'good cause for failure' provision.

Conclusions:

  • PCOs demonstrated creative interpretations of the statutory framework for prescribing incentives.
  • Enhanced use of 'good cause for failure' provisions could mitigate prescribing cost inflation.
  • Further investigation is necessary to ascertain the precise impact of financial incentives on prescribing behavior.